LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME New | Legislative Director, U.S. Representative Jon Porter |
Medicare/Medicaid MMM
Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME New | Legislative Director, U.S. Representative Jon Porter |
Health Issues HCR
Legislation issues impacting PTC Therapeutics, including: H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. MVP Act. Tax Relief for American Families and Workers Act. American Innovation and Jobs Act. ORPHAN Cures Act. American Innovation and R&D Competitiveness Act. Camerons Law.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALANNA TEMME New | Legislative Director, U.S. Representative Jon Porter |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.